Sort
39,280 grants matching “leukemia”
CARRIER MEDIATED ANTIFOLATE TRANSPORT AND RESISTANCE
$489,955Yeshiva University · R01 · FY2002 · CA
Immunoregulatory and effector roles of natural killer cell subsets
$489,954William Joseph Murphy · University Of California At Davis · R01 · FY2019 · HL
The cohesin complex as a tumor suppressor in myeloid leukemia
$489,840Iannis Aifantis · New York University School Of Medicine · R01 · FY2019 · CA
Dendritic Cell Subsets and Paths of Maturation in GVHD
$489,806Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · AI
Vector Integration and Tracking
$489,744Brian C Beard · Seattle Children'S Hospital · P01 · FY2012 · AI
Resequencing
$489,657Seth Daniel Crosby · Washington University · P01 · FY2009 · CA
Aging trajectories and outcomes of older adults with acute myeloid leukemia
$489,655Vijaya Raj Bhatt · University Of Nebraska Medical Center · R37 · FY2024 · CA
Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane
$489,570Hui-Ming Chang · Univ Of Arkansas For Med Scis · R01 · FY2024 · HL
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$489,534Brian Till · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$489,533Brian Till · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
RepSox and its analog for prophylactic intervention in RUNX1 haploinsufficiency FPDMM
$489,500Mortimer Poncz · Children'S Hosp Of Philadelphia · R21 · FY2025 · TR
EASTERN COOPERATIVE ONCOLOGY GROUP
$489,398Fox Chase Cancer Center · U10 · FY2003 · CA
Eastern Cooperative Oncology Group
$489,398Fox Chase Cancer Center · U10 · FY2004 · CA
Flow Cytometric Evaluation of Biomarkers
$489,372Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Illuminating molecular targetable pathways in HNSCC
$489,364Shannon K McWeeney · Oregon Health & Science University · R01 · FY2019 · CA
Cellular and Ion Channel Mechanisms Underlying the Sense of Light Touch in Mammals
$489,359Jianguo Gu · University Of Alabama At Birmingham · R01 · FY2024 · DE
Phase separation-induced nuclear organization in ALT Cancer
$489,357Huaiying Zhang · Carnegie-Mellon University · U01 · FY2023 · CA
MONITORING OF RESIDUAL DISEASE IN PEDIATRIC ALL
$489,347University Of New Mexico · R01 · FY2003 · CA
CD19 Directed CAR Therapy
$489,347Carl H. June · University Of Pennsylvania · R01 · FY2014 · CA
Clinical Consortia (Pediatric & Adult)
$489,222Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$489,159Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$489,159Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia
$489,128Ellen Van Der Plas · Arkansas Children'S Hospital Res Inst · R37 · FY2024 · CA
Project 2: The cohesin complex as a tumor suppressor in myeloid leukemia
$489,106Ari M. Melnick · New York University School Of Medicine · P01 · FY2022 · CA
A novel molecular diagnostic approach to classify lung cancers and predict respon
$489,074Bruce J Mayer · University Of Connecticut Sch Of Med/Dnt · RC1 · FY2010 · CA